KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Evolent Health (EVH) Receivables - Other (2016 - 2021)

Historic Receivables - Other for Evolent Health (EVH) over the last 7 years, with Q1 2021 value amounting to $190000.0.

  • Evolent Health's Receivables - Other fell 8915.53% to $190000.0 in Q1 2021 from the same period last year, while for Mar 2021 it was $190000.0, marking a year-over-year decrease of 8915.53%. This contributed to the annual value of $329000.0 for FY2020, which is 8121.07% down from last year.
  • According to the latest figures from Q1 2021, Evolent Health's Receivables - Other is $190000.0, which was down 8915.53% from $329000.0 recorded in Q4 2020.
  • In the past 5 years, Evolent Health's Receivables - Other registered a high of $10.1 million during Q3 2019, and its lowest value of $190000.0 during Q1 2021.
  • In the last 5 years, Evolent Health's Receivables - Other had a median value of $2.2 million in 2018 and averaged $3.4 million.
  • As far as peak fluctuations go, Evolent Health's Receivables - Other surged by 17160.59% in 2019, and later tumbled by 9333.2% in 2020.
  • Evolent Health's Receivables - Other (Quarter) stood at $5.7 million in 2017, then plummeted by 63.38% to $2.1 million in 2018, then decreased by 16.7% to $1.8 million in 2019, then crashed by 81.21% to $329000.0 in 2020, then crashed by 42.25% to $190000.0 in 2021.
  • Its last three reported values are $190000.0 in Q1 2021, $329000.0 for Q4 2020, and $671000.0 during Q3 2020.